Cb Scientific Stock Performance
| CBSC Stock | USD 0.03 0.01 17.24% |
The firm owns a Beta (Systematic Risk) of -1.85, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning CB Scientific are expected to decrease by larger amounts. On the other hand, during market turmoil, CB Scientific is expected to outperform it. CB Scientific today owns a risk of 12.22%. Please confirm CB Scientific sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to decide if CB Scientific will be following its current price history.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CB Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather fragile basic indicators, CB Scientific may actually be approaching a critical reversion point that can send shares even higher in February 2026. ...more
| Begin Period Cash Flow | 18.7 K | |
| Free Cash Flow | -786 K |
CBSC |
CB Scientific Relative Risk vs. Return Landscape
If you would invest 4.80 in CB Scientific on October 20, 2025 and sell it today you would lose (1.40) from holding CB Scientific or give up 29.17% of portfolio value over 90 days. CB Scientific is currently generating 0.1448% in daily expected returns and assumes 12.2207% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than CBSC, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CB Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CB Scientific's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CB Scientific, and traders can use it to determine the average amount a CB Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0118
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | CBSC |
| Negative Returns |
Based on monthly moving average CB Scientific is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CB Scientific by adding CB Scientific to a well-diversified portfolio.
CB Scientific Fundamentals Growth
CBSC Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CB Scientific, and CB Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CBSC Pink Sheet performance.
| Operating Margin | (14.86) % | |||
| Current Valuation | 20.95 M | |||
| Shares Outstanding | 120.03 M | |||
| Price To Book | 261.27 X | |||
| Price To Sales | 456.11 X | |||
| Revenue | 75.58 K | |||
| EBITDA | (4.8 M) | |||
| Cash And Equivalents | 4.67 K | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (786.03 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 653.97 K | |||
About CB Scientific Performance
By analyzing CB Scientific's fundamental ratios, stakeholders can gain valuable insights into CB Scientific's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CB Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CB Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CB Scientific, Inc., through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally. Its EKG devices, interactive cloud-based acquisition software, and smartphone apps provide improved compliance for patients at risk of abnormal heart rhythms, as well as accurate information for physicians. Cb Scientific operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 5 people.Things to note about CB Scientific performance evaluation
Checking the ongoing alerts about CB Scientific for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CB Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CB Scientific had very high historical volatility over the last 90 days | |
| CB Scientific has some characteristics of a very speculative penny stock | |
| CB Scientific has high likelihood to experience some financial distress in the next 2 years | |
| The company has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist CB Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, CB Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CB Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CBSC to invest in growth at high rates of return. When we think about CB Scientific's use of debt, we should always consider it together with cash and equity. | |
| CB Scientific reported the previous year's revenue of 75.58 K. Net Loss for the year was (6.34 M) with profit before overhead, payroll, taxes, and interest of 23.49 K. | |
| CB Scientific currently holds about 4.67 K in cash with (786.03 K) of positive cash flow from operations. | |
| Latest headline from news.google.com: Intellia Therapeutics Best Nasdaq Stocks Clinical Innovation - Kalkine Media |
- Analyzing CB Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CB Scientific's stock is overvalued or undervalued compared to its peers.
- Examining CB Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CB Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CB Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CB Scientific's pink sheet. These opinions can provide insight into CB Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CBSC Pink Sheet analysis
When running CB Scientific's price analysis, check to measure CB Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CB Scientific is operating at the current time. Most of CB Scientific's value examination focuses on studying past and present price action to predict the probability of CB Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CB Scientific's price. Additionally, you may evaluate how the addition of CB Scientific to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |